Browse by UCL people
Group by: Type | Date
Number of items: 6.
Article
Efthymiou, M;
Arachchillage, DRJ;
Lane, PJ;
O'Keeffe, AG;
McDonnell, T;
Cohen, H;
Mackie, IJ;
(2018)
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Thrombosis Research
, 170
pp. 60-68.
10.1016/j.thromres.2018.08.003.
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
Gardiner, C;
Kohama, K;
Patel, I;
Lane, P;
Dwyer, S;
Machin, SJ;
Mackie, IJ;
(2017)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem (TM) PT).
International Journal of Laboratory Hematology
, 39
(5)
pp. 532-538.
10.1111/ijlh.12691.
|
Lawrie, AS;
Lane, PJ;
Mackie, IJ;
Machin, SJ;
Kobayashi, K;
(2014)
The automation of routine light transmission platelet aggregation.
International Journal of Laboratory Hematology
, 36
(4)
431 - 438.
10.1111/ijlh.12161.
|
Proceedings paper
Efthymiou, M;
Mackie, IJ;
Lane, P;
Erkan, D;
Cohen, H;
(2017)
High prevalence of activated protein C resistance associated with high avidity anti-protein C antibodies in various antiphospholipid syndrome clinical phenotypes.
In:
(Proceedings) ISTH 2017.
|
Poster
Gardiner, C;
Kiyoko, K;
Patel, I;
Lane, P;
Machin, SJ;
Mackie, I;
(2016)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent.
Presented at: UNSPECIFIED.
|